loading page

Acquired epidermodysplasia verruciformis in renal-transplant recipients
  • +3
  • Soumaya Gara,
  • meriem jones,
  • Noureddine Litaiem,
  • Hafedh Hedri,
  • Soumaya Rammeh,
  • Faten Zeglaoui
Soumaya Gara
Charles Nicolle Hospital
Author Profile
meriem jones
Charles Nicolle Hospital
Author Profile
Noureddine Litaiem
Charles Nicolle Hospital
Author Profile
Hafedh Hedri
Charles Nicolle Hospital
Author Profile
Soumaya Rammeh
Charles Nicolle Hospital
Author Profile
Faten Zeglaoui
Charles Nicolle Hospital
Author Profile

Peer review status:UNDER REVIEW

16 Apr 2020Submitted to Clinical Case Reports
25 Apr 2020Submission Checks Completed
25 Apr 2020Assigned to Editor
02 May 2020Reviewer(s) Assigned
25 May 2020Review(s) Completed, Editorial Evaluation Pending
07 Jul 20201st Revision Received
09 Jul 2020Submission Checks Completed
09 Jul 2020Assigned to Editor
09 Jul 2020Reviewer(s) Assigned
09 Jul 2020Review(s) Completed, Editorial Evaluation Pending

Abstract

Acquired epidermodysplasia verruciformis is a rare entity occurring in immunocompromised patients such as organ-transplant recipients. Renal-transplant recipients are at high risk for developing squamous cell carcinomas. The impact of acquired epidermodysplasia verruciformis on this risk is unknown. Long-term follow-up of this high-risk population should be proposed.